Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
The bill makes technical corrections to the Food Safety Modernization Act (FSMA) user-fee provisions to clarify FDA authority to assess and collect food-related reinspection and recall fees, set fee formulas and baseline amounts for certain fees (e.g., $15,000 baseline for several fee categories adjusted annually), require crediting of overestimated carryover fee collections, increase statutory caps on fee collections, define “reinspection,” and establish small-business definitions and procedures (including annual publication and guidance within 270 days for fee reductions). It also specifies that fees for facility/importer oversight and fees for the voluntary qualified importer program (VQIP) be used only for those purposes and requires the Secretary to consider the number of VQIP participants when setting related fees.
Whether the $15,000 baseline and adjusted fees are an appropriate burden: liberals and centrists generally accept them if small-business relief is meaningful; conservatives see them as undue regulatory cost.
Relative to its intended legislative type, this bill is a targeted statutory amendment that clarifies and adjusts FSMA-related fee authorities, sets numeric fee levels and caps, and adds definitional clarity and limited implementation instructions.
The bill makes technical corrections to the Food Safety Modernization Act (FSMA) user-fee provisions to clarify FDA authority to assess and collect food-related reinspection and recall fees, set fee formulas and baseline amounts for certain fees (e.g., $15,000 baseline for several fee categories adjusted annually), require crediting of overestimated carryover fee collections, increase statutory caps on fee collections, define “reinspection,” and establish small-business definitions and procedures (including annual publication and guidance within 270 days for fee reductions).
It also specifies that fees for facility/importer oversight and fees for the voluntary qualified importer program (VQIP) be used only for those purposes and requires the Secretary to consider the number of VQIP participants when setting related fees.
The bill adjusts statutory dollar caps upward (by $5 million in two places), adds numerical small-business thresholds for facilities and importers (with inflation adjustment), and mandates publication of fee schedules and guidance for fee reduction requests.
On content alone, the bill is a narrowly focused, technocratic adjustment to an existing federal user-fee regime with built-in small-business relief and administrative clarifications—characteristics that historically increase the chance a bill will be enacted. The fiscal impact is primarily via user fees rather than large new spending programs, and the bill avoids highly contentious policy areas. Remaining hurdles are stakeholder objections to fee levels, any drafting/formatting ambiguities, and routine legislative process constraints.
Relative to its intended legislative type, this bill is a targeted statutory amendment that clarifies and adjusts FSMA-related fee authorities, sets numeric fee levels and caps, and adds definitional clarity and limited implementation instructions.
Whether the $15,000 baseline and adjusted fees are an appropriate burden: liberals and centrists generally accept them if small-business relief is meaningful; conservatives see them as undue regulatory cost.
These are examples from the analysis, not a ranked list of the most-affected groups.
Whether the $15,000 baseline and adjusted fees are an appropriate burden: liberals and centrists generally accept them if small-business relief is meaningful; conservatives see them as undue regulatory cost.
A mainstream liberal would likely view this bill as a pragmatic, technical fix that helps ensure the FDA has predictable user-fee authority and clearer definitions to carry out food safety oversight and recalls.
They would welcome the explicit restriction that certain fees be used only for oversight and that VQIP fees be used only for that program.
They would watch whether the changes actually strengthen inspection and recall capacity and whether small businesses get meaningful relief.
A mainstream centrist would see this as mostly technical, narrowly targeted corrections to FSMA user-fee law that increase clarity for FDA and regulated entities.
They would value the annual publication requirement, the guidance deadline, and the provision to credit overcollections, while being cautious about the concrete cost impacts on small businesses and whether fee increases are appropriately calibrated.
Overall they would likely support the bill if implementation details and cost estimates are transparent and if there is oversight to prevent fee overreach.
A mainstream conservative would be skeptical of expanding federal fee authorities and raising statutory caps; they would view new or higher mandatory baseline fees and automatic inflation adjustments as another form of regulatory cost and federal expansion.
They would be concerned about burdens on small businesses and importers, and would prefer limiting fee increases, ensuring strict restraints on how the executive uses fee authority, or preserving more market-oriented or state-level flexibility.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone, the bill is a narrowly focused, technocratic adjustment to an existing federal user-fee regime with built-in small-business relief and administrative clarifications—characteristics that historically increase the chance a bill will be enacted. The fiscal impact is primarily via user fees rather than large new spending programs, and the bill avoids highly contentious policy areas. Remaining hurdles are stakeholder objections to fee levels, any drafting/formatting ambiguities, and routine legislative process constraints.
The bill has not accumulated any surfaced votes yet.
Whether the $15,000 baseline and adjusted fees are an appropriate burden: liberals and centrists generally accept them if small-business re…
On content alone, the bill is a narrowly focused, technocratic adjustment to an existing federal user-fee regime with built-in small-busine…
Relative to its intended legislative type, this bill is a targeted statutory amendment that clarifies and adjusts FSMA-related fee authorities, sets numeric fee levels and caps, and adds definitional clarity and limited…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.